Retraction

AIM2 Promotes Gastric Cancer Cell Proliferation via the MAPK Signaling Pathway

Citations (9)

9
Total Citations
5
Post-Retraction
(55.6%)
3
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
681 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The dual roles of human PYHIN family proteins in cancer: mechanisms and therapeutic implications
Shuyan Zeng, Zhiyong Zhou, Yi Li et al. (6 authors)
Frontiers in Immunology Open Access
Published: May 2025
681 days after retraction
BATF-Activated AIM2 Mediates Immune Escape in Lung Adenocarcinoma by Regulating PD-L1
Xiang Liu, Wangyan Zhou, Dayang Zheng et al. (7 authors)
International Archives of Allergy and Immunology
Published: Oct 2024
1 citation
496 days after retraction
<scp>SNHG14</scp> promotes triple‐negative breast cancer cell proliferation, invasion, and chemoresistance by regulating the <scp>ERK</scp>/<scp>MAPK</scp> signaling pathway
Bin Wang, Ai‐Yan Xing, Guangxin Li et al. (5 authors)
IUBMB Life
Published: Sep 2024
5 citations
449 days after retraction
Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
Jun Xu, Jun Yang, Xianzhu Pan et al. (4 authors)
Scientific Reports Open Access
Published: Nov 2023
4 citations
138 days after retraction
Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer
Qian Li, Long-Kuan Yin
World Journal of Clinical Oncology Open Access
Published: Oct 2023
6 citations
121 days after retraction
AIM2 and Psoriasis
Yuxi Zhang, Xiaoqing Xu, Hui Cheng et al. (4 authors)
Frontiers in Immunology Open Access
Published: Jan 2023
18 citations
154 days before retraction
Retracted: AIM2 Promotes Gastric Cancer Cell Proliferation via the MAPK Signaling Pathway
Journal of Healthcare Engineering
Journal of Healthcare Engineering Open Access
Published: Jan 2023
171 days before retraction
Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines
Julia Krushkal, Suleyman Vural, Travis L. Jensen et al. (5 authors)
Clinical Epigenetics Open Access
Published: Dec 2022
4 citations
202 days before retraction
Quick Stats
Total Citations: 16
Years Since Retraction: 2.4 years
Open Access: Yes
Last Checked: Jul 24, 2025